The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis

Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system with unknown etiology. Currently approved disease-modifying treatment modalities are immunomodulatory or immunosuppressive. While the applied drugs reduce the frequency and severity...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cellular and molecular life sciences : CMLS 2020-04, Vol.77 (7), p.1289-1317
Hauptverfasser:	de Jong, Charlotte G. H. M., Gabius, Hans-Joachim, Baron, Wia
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Apoptosis Astrocytes Autoantibodies - blood Autoimmune diseases Biochemistry Biomedical and Life Sciences Biomedicine Cell Biology Central nervous system Demyelination Etiology Galectins - metabolism Glial cells Humans Immunomodulation Immunosuppressive agents Lectins Life Sciences Microglia Models, Biological Multiple sclerosis Multiple Sclerosis - blood Multiple Sclerosis - metabolism Multiple Sclerosis - pathology Multiple Sclerosis - therapy Myelin Myelin Sheath - metabolism Myelination Neurodegenerative diseases Oligodendrocytes Remyelination Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!